Cytox Group Limited provides non-invasive, risk assessment and patient stratification tools for Alzheimer's disease and dementia. Cytox’s mission is to transform how new treatments are developed, people are screened, and how patients are managed within the Alzheimer’s disease care pathway..
genoSCORE™ combines Cytox’s proprietary technologies variaTECT™, a single nucleotide polymorphism (SNP) profiling array, with SNPfitR™analytical and interpretive software, to give …
genoTOR™ characterises an individual’s genetic profile linked to mTOR-regulated signalling pathways, mechanisms known to affect the risk of Alzheimer's and …
No services posted yet
This data is part of our proprietary analytics report:
This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality